We at B-ezy Diagnostics primarily focuses on developing a point of care diagnosis kit for the detection of antibiotic resistance in urinary tract infection in humans. Our assay is going to be very sensitive, specific and very less time consuming than the conventional methods and can give results in just 30-60 minutes of time. Our assay will aid clinicians to prescribe effective antibiotic or its combination to the patient suffering with infection. Our product will target a market ranging from government and private hospitals and diagnostic labs, research institutes and universities. Along with this we are also working on developing diagnostic kits and providing diagnostic services for variety of diseases.

Research and development

Source: Ministry of Corporate Affairs company master (open data). Capital figures are as-of the 2021 registry snapshot, not live.